Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Neurology
    September 2022
  1. BAARS AE, Kuitwaard K, de Koning LC, Luijten LWG, et al
    SARS-CoV-2 Vaccination Safety in Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropath.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201376.
    >> Share

  2. ALLEN JA
    SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the Risk.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201366.
    >> Share

  3. GANESH A, Galetta S
    Editors' Note: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;99:489.
    >> Share

  4. VALE S
    Reader Response: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;99:491.
    >> Share

  5. GUASP M, Dalmau J
    Author Response: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;99:490.
    >> Share

  6. CAROTENUTO A, Valsasina P, Schoonheim MM, Geurts JJ, et al
    Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
    Neurology. 2022 Sep 12. pii: WNL.0000000000201264.
    >> Share

    August 2022
  7. CORDANO C, Nourbakhsh B, Yiu HH, Papinutto N, et al
    Differences in Age-Related Retinal and Cortical Atrophy Rates in Multiple Sclerosis.
    Neurology. 2022 Aug 29. pii: WNL.0000000000200977.
    >> Share

  8. VILLOSLADA P, Llufriu S
    Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease.
    Neurology. 2022 Aug 29. pii: WNL.0000000000201223.
    >> Share

  9. HWANG S, Garcia-Dominguez MA, Fitzgerald KC, Saylor DR, et al
    Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level.
    Neurology. 2022 Aug 24. pii: WNL.0000000000200962.
    >> Share

  10. LOPEZ-JIMENEZ A, Gutierrez-Gutierrez G, Guerra-Hiraldo JD, Kurtis MM, et al
    Teaching Video NeuroImage: Hung-Up Reflex in Stiff Limb Syndrome.
    Neurology. 2022;99:356.
    >> Share

  11. BRENTON JN, Florenzo B, Koshiya H, Min S, et al
    Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201098.
    >> Share

  12. LEONHARD SE, van der Eijk AA, Andersen H, Antonini G, et al
    An International Perspective on Preceding Infections in Guillain-Barre Syndrome: The IGOS-1000 Cohort.
    Neurology. 2022 Aug 18. pii: WNL.0000000000200885.
    >> Share

  13. ROOS I, Malpas C, Leray E, Casey R, et al
    Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201029.
    >> Share

  14. MCLAREN JR, Mitchell MK, Al-Maadid FM, Staley KJ, et al
    Clinical Reasoning: An 8-Year-Old With Acute Onset Ataxia.
    Neurology. 2022;99:305-310.
    >> Share

  15. DOBSON R, Bove R
    IVF and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk.
    Neurology. 2022 Aug 11. pii: WNL.0000000000201242.
    >> Share

  16. MAINGUY M, Tillaut H, Degremont A, Le Page E, et al
    Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis.
    Neurology. 2022 Aug 11. pii: WNL.0000000000201027.
    >> Share

  17. O'MAHONY J, Salter A, Ciftci B, Fox RJ, et al
    Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis.
    Neurology. 2022 Aug 10. pii: WNL.0000000000200931.
    >> Share

  18. SECHI E, Gallus E, Solla P, Puggioni D, et al
    Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis.
    Neurology. 2022;99:256-257.
    >> Share

  19. PIAZZA F, Caminiti SP, Zedde M, Presotto L, et al
    Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-A Autoantibodies.
    Neurology. 2022 Aug 8. pii: WNL.0000000000200892.
    >> Share

  20. BSTEH G, Krajnc N, Riedl K, Altmann P, et al
    Retinal Layer Thinning After Optic Neuritis is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200970.
    >> Share

    June 2022
  21. KENNEY RC, Liu M, Hasanaj L, Joseph B, et al
    The Role of OCT Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.
    Neurology. 2022 Jun 28. pii: WNL.0000000000200883.
    >> Share

  22. TOOSY AT, Eshaghi A
    Machine Learning Utility for Optical Coherence Tomography in Multiple Sclerosis: Is the Future Now?
    Neurology. 2022 Jun 28. pii: WNL.0000000000200862.
    >> Share

  23. FREEDMAN MS, Pozzilli C, Havrdova EK, Lemle A, et al
    Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results from Randomized Phase 2b Core and Extension Studies.
    Neurology. 2022 Jun 6. pii: WNL.0000000000200606.
    >> Share

    May 2022
  24. SOTIRCHOS ES, Vasileiou ES, Filippatou AG, Fitzgerald KC, et al
    Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Neurology. 2022 May 26. pii: WNL.0000000000200778.
    >> Share

  25. GRAVES J
    Identifying Multiple Sclerosis Activity: Do the Eyes Have It?
    Neurology. 2022 May 26. pii: WNL.0000000000200903.
    >> Share

  26. YANG JH, Graves JS
    Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?
    Neurology. 2022;98:737-738.
    >> Share

  27. LANGER-GOULD AM, Gonzales EG, Smith JB, Li BH, et al
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.
    Neurology. 2022;98:e1818-e1827.
    >> Share

  28. GROOME PA, Webber C, Maxwell CJ, McClintock C, et al
    Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and the Diagnostic Interval in Breast and Colorectal Cancer.
    Neurology. 2022;98:e1798-e1809.
    >> Share

    April 2022
  29. WU Q, Zhao CW, Dai S
    Teaching Video NeuroImage: Generalized Reflex Myoclonus in Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome.
    Neurology. 2022 Apr 29. pii: WNL.0000000000200733.
    >> Share

  30. YANG JH, Graves JS
    Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?
    Neurology. 2022 Apr 28. pii: WNL.0000000000200366.
    >> Share

  31. HAMILTON R, Ciccarelli O
    Multiple Sclerosis Incidence in Black Patients: It's Time to Do Away With a Racial Medical Myth.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200309.
    >> Share

  32. LANGER-GOULD AM, Gonzales EG, Smith JB, Li BH, et al
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200151.
    >> Share

  33. GROOME PA, Webber C, Maxwell CJ, McClintock C, et al
    Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and the Diagnostic Interval in Breast and Colorectal Cancer.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200163.
    >> Share

  34. ROTSTEIN D, Solomon JM, Sormani MP, Montalban X, et al
    Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
    Neurology. 2022 Apr 26. pii: WNL.0000000000200549.
    >> Share

  35. OKAI AF, Howard AM, Williams MJ, Brink JD, et al
    Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.
    Neurology. 2022 Apr 25. pii: WNL.0000000000200791.
    >> Share

  36. PORTACCIO E, Bellinvia A, Razzolini L, Pasto L, et al
    Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset.
    Neurology. 2022;98:e1626-e1636.
    >> Share

  37. SWART G, Balgobind S, Chan C, Fulham M, et al
    Spinal Cord Presentation of Biopsy-Proven PET-Positive Giant Cell Arteritis.
    Neurology. 2022 Apr 15. pii: WNL.0000000000200749.
    >> Share

  38. BEBO B, Cintina I, LaRocca N, Ritter L, et al
    Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200150.
    >> Share

  39. OSTKAMP P, Schwab N
    Effects of Latitude and Sunlight on Multiple Sclerosis Severity: Two Peas in a Pod?
    Neurology. 2022 Apr 11. pii: WNL.0000000000200105.
    >> Share

  40. VITKOVA M, Diouf I, Malpas C, Horakova D, et al
    Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
    Neurology. 2022 Apr 11. pii: WNL.0000000000200545.
    >> Share

  41. GUASP M, Martin-Aguilar L, Sabater L, Bioque M, et al
    Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;98:e1489-e1498.
    >> Share

  42. LEPPERT D, Kropshofer H, Haring DAA, Dahlke F, et al
    Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
    Neurology. 2022 Apr 4. pii: WNL.0000000000200258.
    >> Share

    March 2022
  43. GALLAY L, Fermon C, Lessard L, Weiss-Gayet M, et al
    Involvement of Type-I Interferon Signaling in Muscle Stem Cell Proliferation During Dermatomyositis.
    Neurology. 2022 Mar 29. pii: WNL.0000000000200271.
    >> Share

  44. PINAL-FERNANDEZ I, Greenberg SA
    Type I Interferons in Dermatomyositis Myoblasts: Toxic Effect and a Potential Autocrine Loop.
    Neurology. 2022 Mar 29. pii: WNL.0000000000200679.
    >> Share

  45. BOURDETTE D, Sormani MP
    Thinking Anew: Accelerating Clinical Trials of New Therapies for Progressive Multiple Sclerosis.
    Neurology. 2022 Mar 23. pii: WNL.0000000000200597.
    >> Share

  46. LI V, Leurent B, Barkhof F, Braisher M, et al
    Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis.
    Neurology. 2022 Mar 23. pii: WNL.0000000000200604.
    >> Share

  47. MOLIMARD A, Gitiaux C, Barnerias C, Audic F, et al
    Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200288.
    >> Share

  48. BRIDEL C, Killestein J, Teunissen C
    Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022;98:471.
    >> Share

  49. KROPSHOFER H, Haring DA, Kappos L, Leppert D, et al
    Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022;98:470-471.
    >> Share

  50. LEWIS A, Galetta S
    Editors' Note: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022;98:470.
    >> Share

  51. HUMMERT MW, Schoppe LM, Bellmann-Strobl J, Siebert N, et al
    Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE(NMO) Study.
    Neurology. 2022;98:e1184-e1196.
    >> Share

  52. SIMMONS SB, Ontaneda D
    Slowly Expanding Lesions: A New Target for Progressive Multiple Sclerosis Trials?
    Neurology. 2022 Mar 11. pii: WNL.0000000000200230.
    >> Share

  53. AZZOLINI F, Farina A, Gastaldi M, Barilaro A, et al
    Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP-Astrocytopathy.
    Neurology. 2022 Mar 11. pii: WNL.0000000000200291.
    >> Share

  54. CALVI A, Carrasco FP, Tur C, Chard DT, et al
    Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis.
    Neurology. 2022 Mar 11. pii: WNL.0000000000200144.
    >> Share

  55. ZENG YH, Zhao M, Guo XX, Wang N, et al
    Cutaneous Lesions as a Clue to the Etiology of Extensive Intracranial Calcifications: Aicardi-Goutieres Syndrome.
    Neurology. 2022;98:417-418.
    >> Share

  56. LEVISON LS, Thomsen RW, Sindrup SH, Andersen H, et al
    Association Between Incident Cancer and Guillain-Barre Syndrome Development: A Nationwide Case-Control Study.
    Neurology. 2022 Mar 2. pii: WNL.0000000000200015.
    >> Share

  57. HAMILTON RH, Ciccarelli O
    Non-White Participants Matter in White Matter Disease Studies: The Importance of Diversity in Multiple Sclerosis Clinical Trials.
    Neurology. 2022;98:345-346.
    >> Share

    February 2022
  58. MARZOUGHI S, Marulanda L, Ngo D, Chen T, et al
    Pearls & Oy-sters: Delayed Diagnosis of Acute Motor Axonal Neuropathy With Cardiac Arrest.
    Neurology. 2022;98:336-339.
    >> Share

  59. LIE IA, Weeda MM, Mattiesing RM, Mol MAE, et al
    Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review.
    Neurology. 2022 Feb 16. pii: WNL.0000000000200006.
    >> Share

  60. MCELWEE DECKER B, Thibault D, Davis KA, Willis AW, et al
    Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200007.
    >> Share

  61. HACOHEN Y, Ciccarelli O
    New Evidence for EBV Infection as a Cause of Multiple Sclerosis.
    Neurology. 2022 Feb 10. pii: WNL.0000000000200243.
    >> Share

  62. MAMMEN AL
    Inclusion Body Myositis: An Autoimmune or Myodegenerative Disease?
    Neurology. 2022 Feb 7. pii: WNL.0000000000200188.
    >> Share

  63. TORTORELLA C, Aiello A, Gasperini C, Agrati C, et al
    Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
    Neurology. 2022;98:e541-e554.
    >> Share

    January 2022
  64. ONUORAH HM, Charron O, Meltzer E, Montague A, et al
    Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs: A Systematic Review.
    Neurology. 2022 Jan 19. pii: WNL.0000000000013230.
    >> Share

  65. CUTTER GR, Koch MW
    Multiple Sclerosis Diagnostic Criteria: Moving Ahead or Walking in Place?
    Neurology. 2022;98:12-13.
    >> Share

  66. FILIPPI M, Preziosa P, Meani A, Dalla Costa G, et al
    Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
    Neurology. 2022;98:e1-e14.
    >> Share

    December 2021
  67. DOETS AY, Lingsma HF, Walgaard C, Islam B, et al
    Predicting Outcome in Guillain-Barre Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013139.
    >> Share

  68. MIRZA AI, Zhu F, Knox N, Forbes JD, et al
    Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013245.
    >> Share

  69. COSTA AF, Rodriguez A, Martinez P, Blanco DCM, et al
    Teaching Video NeuroImage: Uncommon Neuro-ophthalmic Finding in a Patient With Miller Fisher Syndrome and Past SARS-CoV-2 Infection.
    Neurology. 2021;97:e2431-e2432.
    >> Share

  70. SHELLY S, Klein CJ, Dyck PJB, Paul P, et al
    Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
    Neurology. 2021;97:e2392-e2403.
    >> Share

  71. SEBASTIAN P, Cherbuin N, Barcellos LF, Roalstad S, et al
    Association Between Time Spent Outdoors and Risk of Multiple Sclerosis.
    Neurology. 2021 Dec 8. pii: WNL.0000000000013045.
    >> Share

  72. GRAVES JS, Killestein J
    Reading the "T" Leaves of COVID-19 Vaccine Responses in Multiple Sclerosis.
    Neurology. 2021 Dec 8. pii: WNL.0000000000013166.
    >> Share

  73. TANBOON J, Inoue M, Saito Y, Tachimori H, et al
    Dermatomyositis: Muscle Pathology According to Antibody Subtypes.
    Neurology. 2021 Dec 6. pii: WNL.0000000000013176.
    >> Share

  74. NOWAK RJ, Coffey CS, Goldstein JM, Dimachkie MM, et al
    Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
    Neurology. 2021 Dec 2. pii: WNL.0000000000013121.
    >> Share

    November 2021
  75. NEUPERT DG, Rathke KM, Mikati MA
    Teaching Video NeuroImage: Hereditary Hyperekplexia Mimicking Tonic Seizures in an Infant.
    Neurology. 2021;97:e2248-e2249.
    >> Share

  76. TENCER J, Yum SW
    Teaching NeuroImage: Basal Ganglia T1 Hyperintensity and SWI Signal Diabetic Striatopathy in an 18-Year-Old Man With Type 1 Diabetes Mellitus.
    Neurology. 2021;97:e2148-e2149.
    >> Share

  77. DUMONCEAU AG, Ameli R, Rogemond V, Ruiz A, et al
    Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study.
    Neurology. 2021 Nov 19. pii: WNL.0000000000013087.
    >> Share

    October 2021

  78. Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Oct 29. pii: WNL.0000000000013021.
    >> Share

  79. AMATO A
    Author Response: Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Neurology. 2021;97:841-842.
    >> Share

  80. WILLER J
    Reader Response: Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Neurology. 2021;97:841.
    >> Share

  81. TINTORE M, Cobo-Calvo A, Carbonell P, Arrambide G, et al
    Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome.
    Neurology. 2021;97:e1641-e1652.
    >> Share

  82. AA HOGLUND RA, Meyer HE, Stigum H, Torkildsen O, et al
    Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study.
    Neurology. 2021 Oct 25. pii: WNL.0000000000012957.
    >> Share

  83. KALINCIK T, Tremlett H, Ascherio A
    High BMI In Youths as a Modifiable Risk Factor for Multiple Sclerosis: Weighing Up the Evidence.
    Neurology. 2021 Oct 25. pii: WNL.0000000000012966.
    >> Share

  84. AGHAJAN Y, Mitchell RN, Bhattacharyya S, Hsu TY, et al
    Teaching NeuroImage: Bilateral Middle Cerebellar Peduncle Stroke in Giant Cell Arteritis.
    Neurology. 2021 Oct 19. pii: WNL.0000000000012953.
    >> Share

  85. JANDRIC D, Lipp I, Paling D, Rog D, et al
    Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012834.
    >> Share

  86. SANCHEZ CV, Theel E, Binnicker M, Toledano M, et al
    Autoimmune Encephalitis Post-SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Neurology. 2021 Oct 11. pii: WNL.0000000000012931.
    >> Share

  87. SIMPSON-YAP S, De Brouwer E, Kalincik T, Rijke N, et al
    Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012753.
    >> Share

  88. KILLESTEIN J, Schoonheim MM, Voskuhl RR
    B-Cell Depletion and COVID-19 Severity in Multiple Sclerosis: Remaining Challenges.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012754.
    >> Share

  89. BONACCHI R, Meani A, Pagani E, Marchesi O, et al
    Association of Age at Onset With Gray Matter Volume and White Matter Microstructural Abnormalities in People With Multiple Sclerosis.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012869.
    >> Share

  90. HACOHEN Y, Eshaghi A
    Multiple Sclerosis in Children and Adults: Does Age Matter?
    Neurology. 2021 Oct 4. pii: WNL.0000000000012866.
    >> Share

  91. VRENKEN H, Jenkinson M, Pham D, Guttmann CRG, et al
    Opportunities for Understanding MS Mechanisms and Progression With MRI Using Large-Scale Data Sharing and Artificial Intelligence.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012884.
    >> Share

    September 2021
  92. ZHAO-FLEMING HH, Valencia Sanchez C, Sechi E, Inbarasu J, et al
    CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
    Neurology. 2021;97:e1351-e1358.
    >> Share

  93. MERLO D, Stankovich J, Bai C, Kalincik T, et al
    Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012850.
    >> Share

  94. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Colorectal Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
    Neurology. 2021 Sep 15. pii: WNL.0000000000012634.
    >> Share

  95. TOBIN O
    Early Diagnosis and Treatment is Associated With Improved Outcomes in Patients With Multiple Sclerosis.
    Neurology. 2021 Sep 14. pii: WNL.0000000000012738.
    >> Share

  96. CAMELO-FILHO AE, Estephan EP, Heise CO, Zanoteli E, et al
    Teaching Video NeuroImage: Reflex Facilitation in Lambert-Eaton Myasthenic Syndrome.
    Neurology. 2021;97:e1168-e1169.
    >> Share

  97. MILLER JW
    Inflammation As A Target For Epilepsy Therapy: The Case of Natalizumab.
    Neurology. 2021 Sep 14. pii: WNL.0000000000012768.
    >> Share

  98. GOLDSCHMIDT C, Fox RJ
    Relationship Between Serum Neurofilament Light and Multiple Sclerosis Disability Progression: Clear as Mud.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012755.
    >> Share

  99. TOBIN WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, et al
    Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012782.
    >> Share

  100. BRIDEL C, Leurs CE, van Lierop ZY, van Kempen ZL, et al
    Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012752.
    >> Share

  101. RADCLIFFE C, Potnis K, Peng TJ, DeCroce-Movson E, et al
    Teaching NeuroImage: Papilledema and Pachymeningitis: An Atypical Presentation of Granulomatosis With Polyangiitis.
    Neurology. 2021;97:e1060-e1061.
    >> Share

  102. YEH EA, Bourdette D, Wiendl H
    Longer-Term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012716.
    >> Share

  103. HAUSER SL, Kappos L, Montalban X, Craveiro L, et al
    Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012700.
    >> Share

  104. PALLADINO R, Chataway J, Majeed A, Marrie RA, et al
    Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort Study.
    Neurology. 2021 Sep 1. pii: WNL.0000000000012610.
    >> Share

  105. SALTER A
    Assessment of Biological Interactions Between MS Status and Depression for Mortality.
    Neurology. 2021 Sep 1. pii: WNL.0000000000012615.
    >> Share

    August 2021
  106. RICE J, Xiang XM
    Comparing the Effectiveness of Therapies in People With Secondary Progressive Multiple Sclerosis.
    Neurology. 2021;97:e972-e974.
    >> Share

  107. DOBSON R, Salter A
    Differing Impact of Disease-Modifying Therapy on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?
    Neurology. 2021;97:407-408.
    >> Share

  108. KOCH MW, Mostert JP, Wolinsky JS, Lublin FD, et al
    Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Aug 25. pii: WNL.0000000000012690.
    >> Share

  109. PETERSSON M, Feresiadou A, Jons D, Ilinca A, et al
    Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012604.
    >> Share

  110. KOCH MW, Mostert J, Zhang Y, Wolinsky JS, et al
    Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012603.
    >> Share

  111. FREY J, Kramer J, Castellani R, Sriwastava S, et al
    Clinical Reasoning: A 47-Year-Old With Headache, Vertigo, and Double Vision.
    Neurology. 2021;97:e535-e539.
    >> Share

  112. STRUPP M, Frenzel C, Goldschagg N, Halmagyi GM, et al
    Teaching Video NeuroImage: One Bedside Test, 2 Clinical Signs: One Vestibular, the Other Ocular Motor.
    Neurology. 2021;97:e541-e542.
    >> Share

    July 2021
  113. KARCESKI S
    Myasthenia Gravis: Which Type of Surgery Is Best?
    Neurology. 2021;97:e433-e435.
    >> Share

  114. CHEN T
    Clinical Reasoning: A 68-Year-Old Man With Proximal Weakness and Seizures.
    Neurology. 2021;97:e423-e428.
    >> Share

  115. SECHI E, Krecke KN, Messina SA, Buciuc M, et al
    Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012467.
    >> Share

  116. RASMINSKY M
    GCA Squared.
    Neurology. 2021;97:90-91.
    >> Share

  117. NICHOLAS RS, Rhone EE, Mariottini A, Silber E, et al
    Autologous Haematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: a Real-world Case Series.
    Neurology. 2021 Jul 12. pii: WNL.0000000000012449.
    >> Share

  118. LISAK RP
    [Editorial] At the Junction Where It Happens: Antibodies to LRP4 and Agrin Are Pathogenic in Myasthenia Gravis [re: M/S #2020/169756].
    Neurology. 2021 Jul 7. pii: WNL.0000000000012471.
    >> Share

  119. YU Z, Zhang M, Jing H, Chen P, et al
    Characterization of LRP4/Agrin Antibodies From a Patient with Myasthenia Gravis.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012463.
    >> Share

  120. HACOHEN Y, Kerr W, Waters P
    Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice.
    Neurology. 2021;97:12-13.
    >> Share

  121. AKAISHI T, Takahashi T, Misu T, Kaneko K, et al
    Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2021;97:e1-e12.
    >> Share

  122. GUASP M, Gine-Serven E, Maudes E, Rosa-Justicia M, et al
    Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
    Neurology. 2021;97:e61-e75.
    >> Share

    June 2021
  123. GRAY-RONCAL K, Fitzgerald K, Ryerson LZ, Charvet L, et al
    Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis.
    Neurology. 2021 Jun 30. pii: WNL.0000000000012362.
    >> Share

  124. ROOS I, Leray E, Casey R, Horakova D, et al
    Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis.
    Neurology. 2021 Jun 30. pii: WNL.0000000000012354.
    >> Share

  125. MYERS KA
    Author Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
    Neurology. 2021;96:1105.
    >> Share

  126. FUJIMORI J, Nakashima I
    Reader Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
    Neurology. 2021;96:1104-1105.
    >> Share

  127. VILLACIEROS-ALVAREZ J, Ordas CM, Torres-Gaona G, Diez-Barrio A, et al
    Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy.
    Neurology. 2021;96:e2901-e2902.
    >> Share

  128. HUISKAMP M, Eijlers AJC, Broeders TAA, Pasteuning J, et al
    Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Jun 7. pii: WNL.0000000000012341.
    >> Share

  129. PREZIOSA P, Schoonheim MM
    Ongoing Axonal Injury in Chronic Active Lesions in Multiple Sclerosis: In-Vivo Quantification Using Serum Neurofilament.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012331.
    >> Share

  130. CAMPBELL CREE BA, Arnold DL, Chataway J, Chitnis T, et al
    Secondary Progressive Multiple Sclerosis: New Insights.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012323.
    >> Share

  131. MAGGI P, Kuhle J, Schadelin S, van der Meer F, et al
    Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012326.
    >> Share

    May 2021
  132. SAN MARTIN AH, Cuadrado CA, Arbizu MG, Rabano-Suarez P, et al
    Autoimmune Septin-5 Disease Presenting as Spinocerebellar Ataxia and Nystagmus.
    Neurology. 2021 May 24. pii: WNL.0000000000012240.
    >> Share

  133. ROLLOT F, Fauvernier M, Uhry Z, Vukusic S, et al
    Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
    Neurology. 2021 May 19. pii: WNL.0000000000012224.
    >> Share

  134. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
    Neurology. 2021 May 19. pii: WNL.0000000000012127.
    >> Share

  135. JOLLIFFE EA, Guo Y, Hardy TA, Morris PP, et al
    Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis.
    Neurology. 2021 May 19. pii: WNL.0000000000012230.
    >> Share

  136. TOOSY AT, Kapur K, Nair KV
    Is OCT a Viable Tool to Monitor Disease-Modifying Treatments in RRMS Yet?
    Neurology. 2021;96:927-928.
    >> Share

  137. DAY GS, Yarbrough MY, Kortvelyessy P, Pruss H, et al
    Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
    Neurology. 2021;96:e2546-e2557.
    >> Share

  138. TITULAER MJ, Day GS
    Autoimmune Encephalitis in First Episode Psychoses: All Smoke and No Fire?
    Neurology. 2021 May 12. pii: WNL.0000000000012195.
    >> Share

  139. GIANNOCCARO MP, Liguori R
    Author Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
    Neurology. 2021;96:918-919.
    >> Share

  140. SILVESTRI N
    Reader Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
    Neurology. 2021;96:918.
    >> Share

  141. NERSESJAN V, McWilliam O, Krarup LH, Kondziella D, et al
    Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review.
    Neurology. 2021 May 5. pii: WNL.0000000000012122.
    >> Share


  142. Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Neurology. 2021 May 4. pii: WNL.0000000000011825.
    >> Share

  143. SOLIS-PAZMINO P, Baiu I, Lincango-Naranjo E, Trope W, et al
    Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis.
    Neurology. 2021 May 4. pii: WNL.0000000000012153.
    >> Share

  144. FOX RJ, Kryscio RJ
    A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis.
    Neurology. 2021;96:833-834.
    >> Share

  145. KOCH MW, Sage K, Kaur S, Kim J, et al
    Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.
    Neurology. 2021;96:e2313-e2322.
    >> Share

  146. BAR-OR A, Herman A, Stokmaier D
    Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:870.
    >> Share

  147. HAHN N
    Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:870.
    >> Share

  148. SIEGLER JE, Galetta S
    Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:869.
    >> Share

    April 2021
  149. DUBESSY AL, Tezenas du Montcel S, Viala F, Assouad R, et al
    Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012120.
    >> Share

  150. ZOUVELOU V, Daponte A
    Teaching Video NeuroImages: Resolution of Ptosis After Forceful Eye Closure: Bedside Diagnosis of Myasthenia Gravis.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012100.
    >> Share

  151. LEAVITT VM, Dobson R, Svennigsson A
    Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012101.
    >> Share

  152. SHELLY S, Mills JR, Dubey D, McKeon A, et al
    Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012050.
    >> Share

  153. SALAVISA M, Serrazina F, Pires P, Correia AS, et al
    Teaching Video NeuroImages: Infratentorial Multiple Sclerosis Relapse Presenting as Continuous Hemifacial Myokymia.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012052.
    >> Share

  154. GASPERI C, Hapfelmeier A, Daltrozzo T, Schneider A, et al
    Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012074.
    >> Share

  155. SOLOMON AJ, Ascherio A
    Early Diagnosis of Multiple Sclerosis: Further Evidence for Missed Opportunity.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012087.
    >> Share


  156. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
    Neurology. 2021 Apr 23. pii: WNL.0000000000012021.
    >> Share

  157. EID K, Torkildsen OF, Aarseth J, Flemmen HO, et al
    Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012062.
    >> Share

  158. YEH WZ, Widyastuti PA, Van der Walt A, Stankovich J, et al
    Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
    Neurology. 2021 Apr 20. pii: WNL.0000000000012084.
    >> Share

  159. SHELLY S, Shouman K, Paul P, Engelstad J, et al
    Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus.
    Neurology. 2021;96:e2078-e2089.
    >> Share

  160. NISHIDA H, Kohyama K, Kumada S, Takanashi JI, et al
    Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children.
    Neurology. 2021;96:e2070-e2077.
    >> Share

  161. COLLONGUES N, Alves Do Rego C, Bourre B, Biotti D, et al
    Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder.
    Neurology. 2021;96:e2006-e2015.
    >> Share

  162. LAMBE J, Risher H, Filippatou AG, Murphy OC, et al
    Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011933.
    >> Share

  163. BOURDETTE D, Killestein J
    Quelling Public Fears about Guillain-Barre Syndrome and COVID-19 Vaccination.
    Neurology. 2021 Apr 6. pii: WNL.0000000000011882.
    >> Share

  164. MARQUEZ LOZA AM, Holroyd KB, Johnson SA, Pilgrim DM, et al
    Guillain- Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.
    Neurology. 2021 Apr 6. pii: WNL.0000000000011881.
    >> Share

  165. ALLEN JA, Pasnoor M, Dimachkie MM, Ajroud-Driss S, et al
    Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study.
    Neurology. 2021;96:e1876-e1886.
    >> Share

    March 2021
  166. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    >> Share

  167. GARDIN T, Longbrake EE
    Inducing or "Unmasking" Autoimmunity? The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events.
    Neurology. 2021 Mar 16. pii: WNL.0000000000011812.
    >> Share

  168. LAMBE J, Fitzgerald KC, Murphy OC, Filippatou AG, et al
    Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011788.
    >> Share

  169. VILLOSLADA P, Galetta SL, Toosy A
    Seeing the Finish Line: Can Baseline OCT Values Predict Long-Term Disability and Therapeutic Management in Multiple Sclerosis?
    Neurology. 2021 Mar 2. pii: WNL.0000000000011793.
    >> Share

  170. BANSAL P, Paul BS, Singh G
    Multiple Sclerosis Relapse Presenting As Sensorineural Hearing Loss.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011796.
    >> Share

    February 2021
  171. MUTHUSAMY K, Boyer S, Patterson M, Bierau J, et al
    Neuroimaging Findings in Inosine Triphosphate Pyrophosphohydrolase (ITPase) Deficiency.
    Neurology. 2021 Feb 16. pii: WNL.0000000000011719.
    >> Share

  172. KALAITZIDIS G, Calabresi PA
    Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis?
    Neurology. 2021 Feb 15. pii: WNL.0000000000011694.
    >> Share


  173. Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data.
    Neurology. 2021 Feb 12. pii: WNL.0000000000011677.
    >> Share

  174. SOLE G, Mathis S, Friedman D, Salort-Campana E, et al
    Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011669.
    >> Share

  175. ZEPHIR H, Poupart J, Deschamps R, Audoin B, et al
    Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
    Neurology. 2021;96:295-296.
    >> Share

  176. LEITE MI
    Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
    Neurology. 2021;96:294-295.
    >> Share

  177. DALAKAS MC
    Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?
    Neurology. 2021;96:239-240.
    >> Share

  178. BURT RK, Balabanov R, Han X, Quigley K, et al
    Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
    Neurology. 2021;96:e817-e830.
    >> Share

  179. RIM J, Byler M, Soldatos A, Notarangelo L, et al
    Opinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome.
    Neurology. 2021;96:e956-e959.
    >> Share

  180. VALLAT JM, Duchesne M, Corcia P, Richard L, et al
    The Wide Spectrum of Pathophysiologic Mechanisms of Paraproteinemic Neuropathy.
    Neurology. 2021;96:214-225.
    >> Share

  181. NISHI R, Koike H, Ohyama K, Fukami Y, et al
    Association Between IL-5 Levels and the Clinicopathologic Features of Eosinophilic Granulomatosis With Polyangiitis.
    Neurology. 2021;96:226-229.
    >> Share

    January 2021
  182. ALPING P, Burman J, Lycke J, Frisell T, et al
    Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Non-induction Therapies for Multiple Sclerosis.
    Neurology. 2021 Jan 29. pii: WNL.0000000000011545.
    >> Share

  183. BROWNLEE WJ, Galetta S
    Optic Nerve in Multiple Sclerosis Diagnostic Criteria: An Aye to the Eyes?
    Neurology. 2021;96:139-140.
    >> Share

  184. SORMANI MP, Tur C, Barkhof F
    Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?
    Neurology. 2021;96:141-142.
    >> Share

  185. SPAGNI G, Tricoli L, Modoni A, Monforte M, et al
    Clinical Reasoning: A 71-Year-Old Man Presenting With Acute Onset Dysarthria and Dysphagia.
    Neurology. 2021;96:180-184.
    >> Share

  186. BOFFA G, Massacesi L, Inglese M, Mariottini A, et al
    Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Neurology. 2021 Jan 20. pii: WNL.0000000000011461.
    >> Share

  187. LEAVITT VM, Rocca M
    Siponimod for Cognition in Secondary Progressive Multiple Sclerosis: Thinking Through the Evidence.
    Neurology. 2021;96:91-92.
    >> Share

  188. ROCCA MA, Valsasina P, Meani A, Gobbi C, et al
    Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011494.
    >> Share

  189. PAPP V, Magyari M, Aktas O, Berger T, et al
    Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.
    Neurology. 2021;96:59-77.
    >> Share

  190. GREEN C, Morrison H, Smith P, Golestani F, et al
    Teaching Neuroimages: COVID-19-Associated Acute Disseminated Encephalomyelitis With Corpus Callosal Hemorrhage.
    Neurology. 2021;96:e307-e308.
    >> Share

  191. BOVIS F, Kalincik T, Lublin F, Cutter G, et al
    Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.
    Neurology. 2021;96:e214-e227.
    >> Share

  192. SHAH S, Klassen BT, Flanagan EP
    Paroxysmal Dysarthria-Ataxia in Multiple Sclerosis.
    Neurology. 2021 Jan 5. pii: WNL.0000000000011498.
    >> Share

  193. KALINCIK T, Sormani MP, Tur C
    Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?
    Neurology. 2021;96:12-13.
    >> Share

    December 2020
  194. KALINCIK T, Diouf I, Sharmin S, Malpas C, et al
    Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
    Neurology. 2020 Dec 28. pii: WNL.0000000000011242.
    >> Share


  195. The 2013 clinical course descriptors for multiple sclerosis: A clarification.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011198.
    >> Share

  196. BENEDICT RHB, Tomic D, Cree BA, Fox R, et al
    Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses.
    Neurology. 2020 Dec 16. pii: WNL.0000000000011275.
    >> Share

  197. VIDAL-JORDANA A, Rovira A, Arrambide G, Otero-Romero S, et al
    Optic nerve region in multiple sclerosis diagnosis: the utility of visual evoked potentials.
    Neurology. 2020 Dec 16. pii: WNL.0000000000011339.
    >> Share

  198. LEVISON LS, Thomsen RW, Sindrup SH, Andersen H, et al
    Association of Hospital-Diagnosed Infections and Antibiotic Use with Risk of Developing Guillain-Barre Syndrome.
    Neurology. 2020 Dec 14. pii: WNL.0000000000011342.
    >> Share

  199. GRAUS F, Dalmau J
    Author response: Hashimoto encephalopathy in the 21st century.
    Neurology. 2020;95:1068.
    >> Share

  200. SHUBHAKARAN K
    Reader response: Hashimoto encephalopathy in the 21st century.
    Neurology. 2020;95:1067-1068.
    >> Share

  201. LEE MY, Yong KP, Hyun JW, Kim SH, et al
    Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder.
    Neurology. 2020;95:e3124-e3128.
    >> Share

  202. RUSS JB, Timbie CM, Li Y, Gonzalez-Giraldo E, et al
    Clinical Reasoning: An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions.
    Neurology. 2020;95:e3153-e3159.
    >> Share

  203. TANBOON J, Inoue M, Hirakawa S, Tachimori H, et al
    Pathological features of anti-Mi-2 dermatomyositis.
    Neurology. 2020 Dec 4. pii: WNL.0000000000011269.
    >> Share

  204. NISHIJIMA H, Suzuki C, Kon T, Nakamura T, et al
    Bilateral Thalamic Lesions Associated with Atezolizumab-induced Autoimmune Encephalitis.
    Neurology. 2020 Dec 2. pii: WNL.0000000000011297.
    >> Share

  205. NAISMITH RT, Bermel RA, Coffey CS, Goodman AD, et al
    Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study.
    Neurology. 2020 Dec 2. pii: WNL.0000000000011314.
    >> Share

  206. LANGESKOV-CHRISTENSEN M, Grondahl Hvid L, Nygaard MKE, Ringgaard S, et al
    Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011241.
    >> Share

  207. BINZER S, Manouchehrinia A, Hillert J
    Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1026.
    >> Share

  208. BSTEH G, Berger T
    Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025-1026.
    >> Share

  209. GANESH A, Galetta S
    Editors' note: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025.
    >> Share

  210. SPATOLA M, Petit Pedrol M, Maudes E, Simabukuro M, et al
    Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
    Neurology. 2020;95:e3012-e3025.
    >> Share

    November 2020
  211. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study.
    Neurology. 2020 Nov 25. pii: WNL.0000000000011219.
    >> Share

  212. LI V, Malladi P, Simeoni S, Pakzad M, et al
    A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.
    Neurology. 2020;95:e2924-e2934.
    >> Share

  213. MANTEGAZZA R, Wolfe GI, Muppidi S, Wiendl H, et al
    Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension.
    Neurology. 2020 Nov 23. pii: WNL.0000000000011207.
    >> Share

  214. BRIL V, Benatar M, Andersen H, Vissing J, et al
    Efficacy and safety of rozanolixizumab in moderate-to-severe generalised myasthenia gravis: A phase 2 RCT.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011108.
    >> Share

  215. FEIBEL RM
    Henry R. Viets, MD, and the history of myasthenia gravis.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011239.
    >> Share

  216. NARAYANASWAMI P, Sanders DB, Wolfe G, Benatar M, et al
    International consensus guidance for management of myasthenia gravis: 2020 update.
    Neurology. 2020 Nov 3. pii: WNL.0000000000011124.
    >> Share

  217. HOANG P, Hurtubise B, Muppidi S
    Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
    Neurology. 2020;95:840-843.
    >> Share

    October 2020
  218. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    Reliability of outcome measures in clinical trials in secondary progressive multiple sclerosis.
    Neurology. 2020 Oct 26. pii: WNL.0000000000011123.
    >> Share

  219. KLEIN DA COSTA B, Brant de Souza Melo R, Passos GRD, Gomes Meneses Sevilha Castro D, et al
    Unraveling B lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets.
    Neurology. 2020;95:733-744.
    >> Share

  220. MASTRANGELO V, Asioli GM, Foschi M, Padroni M, et al
    Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease.
    Neurology. 2020;95:648-649.
    >> Share

  221. FELIPE-RUCIAN A, Wegener-Panzer A, Nassenstein I, Reindl M, et al
    Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies.
    Neurology. 2020;95:e2045-e2046.
    >> Share

    September 2020
  222. RINGELSTEIN M, Harmel J, Zimmermann H, Brandt AU, et al
    Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;95:610.
    >> Share

  223. CHEN JJ
    Reader response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;95:609-610.
    >> Share

  224. GIANNOCCARO MP, Paolucci M, Zenesini C, Di Stasi V, et al
    Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis.
    Neurology. 2020;95:e1800-e1806.
    >> Share


  225. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.
    Neurology. 2020 Sep 16. pii: WNL.0000000000008927.
    >> Share

  226. MOCCIA M, van de Pavert S, Eshaghi A, Haider L, et al
    Pathological correlates of the magnetization transfer ratio in multiple sclerosis.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010909.
    >> Share

  227. SHELLY S, Paul P, Bi H, Dubey D, et al
    Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010910.
    >> Share

  228. ROTSTEIN DL, Yeh EA
    Could wider social networks prevent disability in MS and other neurologic disorders?
    Neurology. 2020;95:463-464.
    >> Share

  229. LIBERATORE G, De Santis T, Doneddu PE, Gentile F, et al
    Clinical Reasoning: A case of COVID-19 associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.
    Neurology. 2020 Sep 11. pii: WNL.0000000000010817.
    >> Share

  230. KULICK-SOPER CV, McKee JL, Wolf RL, Mohan S, et al
    Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.
    Neurology. 2020;95:454-457.
    >> Share

  231. VIRHAMMAR J, Kumlien E, Fallmar D, Frithiof R, et al
    Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.
    Neurology. 2020;95:445-449.
    >> Share

  232. BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
    Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:409.
    >> Share

  233. NI J, Xu X
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:408-409.
    >> Share

  234. SIEGLER JE 3RD, Galetta S
    Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:408.
    >> Share

  235. SEESE RR, Guillen D, Gaesser JM, Abdel-Hamid HZ, et al
    Clinical Reasoning: A 14-year-old boy with acute weakness, paresthesias, and headache.
    Neurology. 2020;95:e1285-e1289.
    >> Share

  236. KWON YN, Jung JH, Kim SJ, Sung JJ, et al
    Progressive brain atrophy and white matter changes in MOG encephalomyelitis.
    Neurology. 2020;95:402-403.
    >> Share

    August 2020
  237. BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
    Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:370.
    >> Share

  238. VAVOUGIOS GD
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:369.
    >> Share

  239. VAIRA LA, Salzano G, De Riu G
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:368-369.
    >> Share

  240. LEWIS A, Galetta S
    Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:368.
    >> Share

  241. WALLIN MT
    Initial highly effective therapy for MS: A strong start.
    Neurology. 2020;95:e1114-e1116.
    >> Share

  242. SECHI E, Markovic SN, McKeon A, Dubey D, et al
    Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
    Neurology. 2020 Aug 13. pii: WNL.0000000000010632.
    >> Share

  243. DOUGHTY CT, Guidon AC
    Stronger together: Diagnostic testing for ocular myasthenia gravis.
    Neurology. 2020 Aug 11. pii: WNL.0000000000010616.
    >> Share

  244. RUPRECHT K, Pfuhl C, Oechtering J
    Author response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:277-278.
    >> Share

  245. ALCALA C, Perez-Miralles FC, Gil-Perotin S, Casanova B, et al
    Reader response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:277.
    >> Share

  246. SIEGLER JE 3RD, Galetta S
    Editors' note: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:276.
    >> Share

  247. OUTTERYCK O, Lopes R, Drumez E, Labreuche J, et al
    Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome.
    Neurology. 2020;95:e733-e744.
    >> Share

  248. VAN KEMPEN ZLE, Hoogervorst ELJ, Wattjes MP, Kalkers NF, et al
    Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial.
    Neurology. 2020;95:e745-e754.
    >> Share

  249. DIXON L, Shah S
    Teaching NeuroImages: Hypertrophic polyneuropathy.
    Neurology. 2020;95:e779-e780.
    >> Share

  250. LEE I, Kuo HC, Aban IB, Cutter GR, et al
    Minimal manifestation status and prednisone withdrawal in the MGTX trial.
    Neurology. 2020;95:e755-e766.
    >> Share

  251. ARINO H, Munoz-Lopetegi A, Martinez-Hernandez E, Armangue T, et al
    Sleep disorders in anti-NMDAR encephalitis.
    Neurology. 2020;95:e671-e684.
    >> Share

  252. LEVIN SN, Riley CS, Dhand A, White CC, et al
    Association of Social Network Structure and Physical Function in Patients With Multiple Sclerosis.
    Neurology. 2020 Aug 7. pii: WNL.0000000000010460.
    >> Share

  253. MENDOZA M, Tran C, Bril V, Katzberg HD, et al
    Patient-acceptable symptom states in myasthenia gravis.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010574.
    >> Share

  254. PIEHL F, Wolfe GI
    Is the treatment of myasthenia gravis improving? Why not ask our patients?
    Neurology. 2020 Aug 5. pii: WNL.0000000000010578.
    >> Share

  255. DINKIN M, Gao V, Kahan J, Bobker S, et al
    COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.
    Neurology. 2020;95:221-223.
    >> Share

  256. GUTIERREZ-ORTIZ C, Mendez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, et al
    Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:e601-e605.
    >> Share

  257. NELSON LM, Bourdette D
    Two decades of research: Time to incorporate comorbidity management into the care of MS?
    Neurology. 2020;95:193-194.
    >> Share

  258. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    >> Share

  259. BOSE G, Fitzpatrick T, Yogendrakumar V, Zwicker JC, et al
    Clinical Reasoning: A 73-year-old man with recurrent aphasia, headaches and confusion.
    Neurology. 2020 Aug 4. pii: WNL.0000000000010475.
    >> Share

    July 2020
  260. KILLESTEIN J, Du Pasquier R, Hemmer B
    Vaccination in B-cell depleted MS patients.
    Neurology. 2020 Jul 29. pii: WNL.0000000000010378.
    >> Share

  261. BAR-OR A, Calkwood JC, Chognot C, Evershed J, et al
    Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
    Neurology. 2020 Jul 29. pii: WNL.0000000000010380.
    >> Share

  262. VILLOSLADA P, Sanchez-Dalmau B, Galetta S
    Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosis.
    Neurology. 2020 Jul 28. pii: WNL.0000000000009840.
    >> Share

  263. HAUSER SL, Kappos L, Arnold DL, Bar-Or A, et al
    Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010376.
    >> Share

  264. SANTORO JD, Waltz M, Aaen G, Belman A, et al
    Pediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010414.
    >> Share

  265. KAPOOR R, Smith KE, Allegretta M, Arnold DL, et al
    Serum neurofilament light as a biomarker in progressive multiple sclerosis.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010346.
    >> Share

  266. HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
    Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010369.
    >> Share

  267. HERMAN C, Mayer K, Sarwal A
    Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.
    Neurology. 2020;95:77-84.
    >> Share

  268. CHEN JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, et al
    Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
    Neurology. 2020;95:e111-e120.
    >> Share

  269. MANISCALCO GT, Mariotto S, Hoftberger R, Capra R, et al
    GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010310.
    >> Share

  270. GIOVANNONI G, Knappertz V, Steinerman JR, Tansy AP, et al
    A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010284.
    >> Share

  271. FERREIRA D, Ferro D, Bastos G, Pinto M, et al
    Teaching NeuroImages: Useless (and restless) hand of Oppenheim in multiple sclerosis.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010261.
    >> Share

  272. TOMSCHIK M, Hilger E, Rath J, Mayer EM, et al
    Subgroup Stratification and Outcome in Recently Diagnosed Generalized Myasthenia Gravis.
    Neurology. 2020 Jul 8. pii: WNL.0000000000010209.
    >> Share

  273. BURON MD, Chalmer TA, Sellebjerg F, Barzinji I, et al
    Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
    Neurology. 2020 Jul 7. pii: WNL.0000000000010135.
    >> Share

    June 2020
  274. PONCIANO A, Carvalho JN, Gala D, Leite J, et al
    Pearls & Oy-sters: Guillain-Barre syndrome: An unusual presentation of acute intermittent porphyria.
    Neurology. 2020 Jun 19. pii: WNL.0000000000009838.
    >> Share

  275. RUITER AM, Naber WC, Tannemaat MR, Verschuuren JJGM, et al
    The face of myasthenia gravis.
    Neurology. 2020 Jun 10. pii: WNL.0000000000009782.
    >> Share

  276. JONSSON DI, Sveinsson O, Hakim R, Brundin L, et al
    Author response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
    Neurology. 2020;94:1049-1050.
    >> Share

  277. PAPP V, Petersen T, Magyari M, Koch-Henriksen N, et al
    Reader response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
    Neurology. 2020;94:1048-1049.
    >> Share

  278. VAN KEMPEN ZLE, Kryscio RJ, Dalla Costa G
    Serum neurofilament light as a prognostic marker for MS disability: Are we there yet?
    Neurology. 2020;94:1013-1014.
    >> Share

  279. DAVION JB, Lopes R, Drumez E, Labreuche J, et al
    Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
    Neurology. 2020;94:e2468-e2478.
    >> Share

  280. BIRCA V, Saint-Martin C, Myers KA
    Teaching Video NeuroImages: Pathologic yawning: A sign of brainstem involvement in acute disseminated encephalomyelitis?
    Neurology. 2020;94:e2497-e2498.
    >> Share

  281. COSTELLO F, Dalakas MC
    Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
    Neurology. 2020 Jun 2. pii: WNL.0000000000009921.
    >> Share

  282. ALLENBACH Y, Uzunhan Y, Toquet S, Leroux G, et al
    Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
    Neurology. 2020 Jun 2. pii: WNL.0000000000009727.
    >> Share

  283. GUIDON AC, Amato AA
    COVID-19 and neuromuscular disorders.
    Neurology. 2020;94:959-969.
    >> Share

  284. MARRIE RA, Leavitt VM
    Disease-modifying therapies as cognition-modifying therapies? Treating cognitive impairment in MS.
    Neurology. 2020;94:957-958.
    >> Share

  285. MARTINEZ-HERNANDEZ E, Guasp M, Garcia-Serra A, Maudes E, et al
    Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.
    Neurology. 2020;94:e2302-e2310.
    >> Share

  286. CORREALE J, Marrodan M, Benarroch EE
    What is the role of axonal ion channels in multiple sclerosis?
    Neurology. 2020 Jun 1. pii: WNL.0000000000009754.
    >> Share

    May 2020
  287. LUBLIN FD, Coetzee T, Cohen JA, Marrie RA, et al
    The 2013 clinical course descriptors for multiple sclerosis: A clarification.
    Neurology. 2020 May 29. pii: WNL.0000000000009636.
    >> Share

  288. RAFAY MF, Shapiro KA, Surmava AM, deVeber GA, et al
    Spectrum of cerebral arteriopathies in children with arterial ischemic stroke.
    Neurology. 2020 May 26. pii: WNL.0000000000009557.
    >> Share

  289. MANOUCHEHRINIA A, Stridh P, Khademi M, Leppert D, et al
    Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis.
    Neurology. 2020 May 20. pii: WNL.0000000000009571.
    >> Share

  290. LANDMEYER NC, Burkner PC, Wiendl H, Ruck T, et al
    Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
    Neurology. 2020 May 19. pii: WNL.0000000000009522.
    >> Share

  291. LAMBE J, Rothman A, Prince J, Saidha S, et al
    Retinal pathology occurs in stiff-person syndrome.
    Neurology. 2020;94:e2126-e2131.
    >> Share

  292. DALE RC, Rostasy K
    Autoimmune pediatric neuropsychiatric symptoms with pain and hypertension: CASPR2 antibody.
    Neurology. 2020 May 18. pii: WNL.0000000000009521.
    >> Share

  293. SYRBE S, Stettner GM, Bally J, Borggraefe I, et al
    CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
    Neurology. 2020 May 18. pii: WNL.0000000000009523.
    >> Share

  294. MATHIS S, Soulages A, Le Masson G, Vallat JM, et al
    History of acute polyradiculoneuropathy (part 2): From 1916 to 2019.
    Neurology. 2020;94:836-840.
    >> Share

  295. VAN OMMEREN R, Izenberg A, Shadowitz S, Aviv R, et al
    Clinical Reasoning: An 81-year-old woman with decreased consciousness and fluctuating right facial droop.
    Neurology. 2020;94:843-848.
    >> Share

  296. CORTESE M, Munger KL, Martinez-Lapiscina EH, Barro C, et al
    Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
    Neurology. 2020;94:e1950-e1960.
    >> Share

  297. GADOT R, Nascimento FA, Mims M, Nunez-Wallace K, et al
    Clinical Reasoning: A 59-year-old woman with multiple myeloma and lower extremity weakness and numbness.
    Neurology. 2020;94:794-800.
    >> Share

    April 2020
  298. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    >> Share

  299. MATHIS S, Soulages A, Vallat JM, Le Masson G, et al
    History of acute polyradiculoneuropathy (part 1): The prehistory of Guillain-Barre syndrome.
    Neurology. 2020 Apr 28. pii: WNL.0000000000009401.
    >> Share

  300. KIM HW, Lamb C, Jamali S, Lopez Chiriboga AS, et al
    Mystery Case: Anti-NMDAR encephalitis with overlapping demyelinating syndrome.
    Neurology. 2020;94:e1866-e1869.
    >> Share

  301. NISHI R, Koike H, Ohyama K, Fukami Y, et al
    Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.
    Neurology. 2020;94:e1726-e1737.
    >> Share

  302. POUPART J, Giovannelli J, Deschamps R, Audoin B, et al
    Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
    Neurology. 2020;94:e1645-e1656.
    >> Share

  303. HUSSEIN O, Jordan Z, Abd Elazim A, Stino A, et al
    Pearls & Oy-sters: Rapid progression of prion disease associated with transverse myelitis: A rare presentation.
    Neurology. 2020;94:e1670-e1672.
    >> Share

  304. LANGER-GOULD A, Smith JB, Albers KB, Xiang AH, et al
    Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.
    Neurology. 2020 Apr 13. pii: WNL.0000000000009374.
    >> Share

  305. DOBSON R, Mowry EM
    Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.
    Neurology. 2020 Apr 13. pii: WNL.0000000000009369.
    >> Share

  306. MEALY MA, Kozachik SL, Cook LJ, Totonis L, et al
    Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.
    Neurology. 2020 Apr 8. pii: WNL.0000000000009370.
    >> Share

  307. LEAVITT VM
    Neurologic determinism? Key update to an age-old debate.
    Neurology. 2020;94:605-606.
    >> Share

  308. BROWNLEE W, Bourdette D, Broadley S, Killestein J, et al
    Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
    Neurology. 2020 Apr 2. pii: WNL.0000000000009507.
    >> Share

    March 2020
  309. CARVALHO NETO EG, Gomes MF, Dos Santos IP, Monteiro MD, et al
    Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis: The phenomenon of enhanced ptosis.
    Neurology. 2020 Mar 31. pii: WNL.0000000000009238.
    >> Share

  310. DE MEEL RHP, Keene KR, Wirth MA, Weber KP, et al
    Repetitive ocular vestibular evoked myogenic potentials in myasthenia gravis.
    Neurology. 2020 Mar 26. pii: WNL.0000000000009306.
    >> Share

  311. GRONSETH GS, Barohn R, Narayanaswami P
    Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2020 Mar 25. pii: WNL.0000000000009294.
    >> Share

  312. ARGYROPOULOS GPD, Moore L, Loane C, Roca-Fernandez A, et al
    Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis.
    Neurology. 2020;94:e1320-e1335.
    >> Share

  313. YEH EA, Sormani MP
    Tracking therapies in MS: More evidence in favor of neurofilament.
    Neurology. 2020;94:465-466.
    >> Share

  314. RICE J, Woltjer R, Stienstra N, Sun E, et al
    Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage.
    Neurology. 2020;94:e992-e995.
    >> Share

    February 2020
  315. MACARON G, Willis MA, Ontaneda D, Fernandez H, et al
    Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.
    Neurology. 2020;94:273-275.
    >> Share

  316. KAPOOR M, Spillane J, Englezou C, Sarri-Gonzalez S, et al
    Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.
    Neurology. 2020;94:e635-e638.
    >> Share

  317. LIPKA AF, Boldingh MI, van Zwet EW, Schreurs MWJ, et al
    Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.
    Neurology. 2020;94:e511-e520.
    >> Share

    January 2020
  318. HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
    Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies.
    Neurology. 2020 Jan 20. pii: WNL.0000000000008978.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016